U.S. Markets closed

What Emergent’s latest $535M contract means for national ‘smallpox franchise’

Sara Gilgore
What Emergent’s latest $535M contract means for national ‘smallpox franchise’

The product is the only therapy approved by the Food and Drug Administration for smallpox vaccine complications.